Italy's Snia faces $580 million takeover
This article was originally published in Clinica
Executive Summary
Snia, the Italian biomedical and chemicals group specialising in cardiovascular implantable devices, is facing a E670 million ($578 million) takeover, after unlisted Italian holding company Bios announced on January 29 a bid of E1.80 per share for the 71.2% of stock it does not own. Shares in the company were standing at around E1.90 as Clinica went to press, having risen from around E1.20 in mid-November.